Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04174937Phase 1Completed
Phase 1, randomised, double-blind trial in respiratory tract infection (RTI) (2 arms), sponsored by Scientific Center for Anti-Infectious Drugs. Primary endpoint: Adverse Events up to 90 days. Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04174937.